These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 560890)

  • 21. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents.
    Ginos JZ; Doroski D
    J Pharmacol Exp Ther; 1979 Apr; 209(1):79-86. PubMed ID: 571017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of x-ray irradiation on the effects of apomorphine and L-dopa with respect to the dopamine level in rat brain and corpus striatum.
    Markovska V; Georgiev V; Ankov V
    Acta Physiol Pharmacol Bulg; 1979; 5(4):27-34. PubMed ID: 543408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
    Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selective dopaminergic regulation of stereotyped forms of aggressive and defensive behavior].
    Podol'skiĭ IIa
    Biull Eksp Biol Med; 1977 Apr; 83(4):432-4. PubMed ID: 558022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Participation of the serotoninergic system of the brain in regulation of emotional reactivity].
    Allikmets LKh; Zharkovskiĭ AM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(6):1284-91. PubMed ID: 128934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural and biochemical changes following chronic administration of L-dopa to rats.
    Pycock C; Dawbarn D; O'Shaughnessy C
    Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the roles of dopamine and noradrenaline in animal behaviour.
    Laverty R
    Prog Neurobiol; 1975; 3():33-70. PubMed ID: 240185
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid and prolonged facilitation of stereotyped motor behavior (verticalization) induced by apomorphine in mice previously submitted to stimulation of dopaminergic receptors].
    Costentin J; Marçais H; Protais P; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):913-6. PubMed ID: 820479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.
    Lloyd KG; Willigens MT; Goldstein M
    Psychopharmacology Suppl; 1985; 2():200-10. PubMed ID: 2987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-dopa and apomorphine disrupt long- but not short-behavioural chains.
    Schmidt WJ
    Physiol Behav; 1984 Nov; 33(5):671-80. PubMed ID: 6522487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 38. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?
    Tufik S; Lindsey CJ; Carlini EA
    Pharmacology; 1978; 16(2):98-105. PubMed ID: 201949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ontogenesis of rearing and stereotypy responses to apomorphine in the rat.
    Nomura Y; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):69-73. PubMed ID: 7193721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered response to apomorphine in 6-hydroxydopamine-treated rats.
    Schoenfeld R; Uretsky N
    Eur J Pharmacol; 1972 Jul; 19(1):115-8. PubMed ID: 5048659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.